FDA Approved Products

Application #TypeSponsorNotesProduct #Drug NameFormStrengthActive IngredientApproval DateMarketing StatusReference Standard
021859BLAHALOZYME THERAP001HYLENEX RECOMBINANTINJECTABLE;INJECTION150 UNITS/MLHYALURONIDASE RECOMBINANT HUMAN2005-12-02PrescriptionNo